Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)

In addition to spliceosome gene mutations, oncogene expression and drug resistance in AML might influence exon expression. We performed exon-array analysis and exon-specific PCR (ESPCR) to identify specific landscapes of exon expression that are associated with DEK and WT1 oncogene expression and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Aminetou Mint, Balsat, Marie, Thenoz, Morgan, Koering, Catherine, Payen-Gay, Lea, Cheok, Meyling, Mortada, Hussein, Auboeuf, Didier, Pinatel, Christiane, El-Hamri, Mohamed, Dumontet, Charles, Cros, Emeline, Flandrin-Gresta, Pascale, Nibourel, Olivier, Preudhomme, Claude, Michallet, Mauricette, Thomas, Xavier, Nicolini, Franck, Solly, Françoise, Guyotat, Denis, Campos, Lydia, Wattel, Eric, Mortreux, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823079/
https://www.ncbi.nlm.nih.gov/pubmed/26284582
http://dx.doi.org/10.18632/oncotarget.3898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823079/
https://www.ncbi.nlm.nih.gov/pubmed/26284582
http://dx.doi.org/10.18632/oncotarget.3898

Ejemplares similares